SOFWF (Sofwave Medical) 14-Day RSI: 13.27 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SOFWF Sofwave Medical Ltd SOFWF
44 GF Score
Price $14.16
GF Value $9.86
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Sofwave Medical 14-Day RSI?

Sofwave Medical SOFWF 44 14-Day RSI is 13.27 as of Jul. 17, 2026. GuruFocus rates SOFWF with a GF Score™ of 44/100 and a GF Value™ of $9.86 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Sofwave Medical ranks worse than 85.6% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-07-17), Sofwave Medical's 14-Day RSI is 13.27.

The industry rank for Sofwave Medical's 14-Day RSI or its related term are showing as below:

SOFWF's 14-Day RSI is ranked worse than
85.6% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 49.005 vs SOFWF: 13.27

Sofwave Medical  (OTCPK:SOFWF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Sofwave Medical 14-Day RSI Related Terms


SOFWF vs ABT, SYK, MDT: 14-Day RSI Comparison

For the Medical Devices subindustry, Sofwave Medical's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sofwave Medical 14-Day RSI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Sofwave Medical's 14-Day RSI falls into.


SOFWF
44GF Score
Sofwave Medical Ltd SOFWF
14-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sofwave Medical  (OTCPK:SOFWF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 14-Day RSI →
What does a 14-Day RSI of 13.27 mean?
Sofwave Medical (SOFWF) has a 14-Day RSI of 13.27 as of Jul. 17, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Sofwave Medical and its competitors. According to the industry distribution chart, Sofwave Medical ranks #743 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 85.6%.
Is Sofwave Medical's 14-Day RSI too high?
Sofwave Medical's current 14-Day RSI is 13.27. The Medical Devices & Instruments industry median 14-Day RSI is 49.01. Sofwave Medical's value of 13.27 is 72.9% below this industry median. Based on the distribution chart, Sofwave Medical ranks #743 out of 868 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sofwave Medical has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #743 out of 868 companies for 14-Day RSI. This places Sofwave Medical in the lower half of its industry. The industry median 14-Day RSI is 49.01. Sofwave Medical's value of 13.27 is 72.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 49.01, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sofwave Medical's current 14-Day RSI of 13.27 is 72.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Sofwave Medical and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 49.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sofwave Medical's current 14-Day RSI is 13.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.86, compared to a current price of $14.16 — trading 43.6% above its estimated fair value. The current 14-Day RSI is 13.27 and 72.9% below the Medical Devices & Instruments industry median of 49.01. Sofwave Medical's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current 14-Day RSI is 13.27 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sofwave Medical (SOFWF) Overvalued in 2026?

Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued. The current stock price of $14.16 is trading 43.6% above its estimated GF Value™ of $9.86. GuruFocus considers Sofwave Medical to be Significantly Overvalued.

Key valuation signals for SOFWF:

  • 14-Day RSI: 13.27
  • GF Value™: $9.86 vs. price of $14.16 (43.6% above fair value)
  • GF Score™: 44/100 with 5 warning signs
  • Industry Position: 72.9% below the Medical Devices & Instruments median (#743 of 868)

No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sofwave Medical Business Description

Other Exchanges SOFW:Israel
Address Oak Medtech, Tavor, Alon Medtech Venture, Yokneam Illit, ISR, 2069200
Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.
44GF Score

Get the complete analysis for SOFWF

14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.16
Price
$9.86
GF Value